Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Trend Exploration, Inc. (TRDX)
Jericho, NY, US
Trend Exploration, Inc. serves as a specialized provider for the medical, dental, and veterinary sectors. The company maintains an extensive catalog of offerings, ranging from vital consumables such as anesthetics, disposable items, and infection control solutions, to an array of instruments, equipment like handpieces and X-ray units, and diverse materials for restorative work, orthodontics, and surgical procedures, including acrylics, alloys, cements, and crowns. This firm was established in 1987 and conducts its operations from its headquarters in Jericho, New York.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +73.68% | +73.68% | +73.68% | +22.22% | +37.50% | -5.71% | +0.00% | -8.33% | -75.19% | -89.75% | -89.75% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Shell Companies: +20.6%—
-
EPS growth Shell Companies: -12.3%+11.8% ★ Q1'26: +200.0% (vs Q3'24)
-
FCF margin FCF growth · Shell Companies: +8.7%—
-
EBIT margin Shell Companies: +0.0%—
-
ROIC Shell Companies: +0.0%— Q1'26: +11.9% (vs Q3'24)
-
Share dilution Shell Companies: -10.2%+0.0% ★ Q1'26: +0.0% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Shell Companies: 0.00×— Q1'26: 0.00× (vs Q3'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Executive team
Executive team data is not available for this company yet.
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TRDX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
